Sign in

CIK 0001359931

  • Non-accelerated filer
  • Smaller reporting company

Protara Therapeutics, Inc.

Sign in to watch
Ticker
TARA
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Entity type
Operating
EIN
204580525
Phone
+1 646-844-0337
Business address
345 PARK AVENUE SOUTH, 3RD FLOOR, NEW YORK, NY, 10010
Former names
Protara Therapeutics, Inc., ArTara Therapeutics, Inc., PROTEON THERAPEUTICS INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 31 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2020-01-09 Opaleye, L.P. 10% owner Grant or award +1,426,234 $7.01 $10.0M 2,208,472
2019-11-12 Haines Timothy Former Director and 10% Owner Conversion +126,645 $0.99 $126K 2,144,517
2019-11-12 Haines Timothy Former Director and 10% Owner Conversion · Series A Convertible Preferred Stock −126 2,400
2019-11-12 Abingworth LLP Former 10% Owner Conversion +126,645 $0.99 $126K 2,144,517
2019-11-12 Abingworth LLP Former 10% Owner Conversion · Series A Convertible Preferred Stock −126 2,400
2019-11-08 Freund John Gordon Director Conversion +703,588 $0.99 $700K 2,175,882
2019-11-08 Freund John Gordon Director Conversion · Series A Convertible Preferred Stock −700 354
2019-03-15 Burke Steven Keith SVP and Chief Medical Officer Gift −7,334 116,584
2019-03-15 Burke Steven Keith SVP and Chief Medical Officer Gift −7,333 109,251
2019-03-15 Burke Steven Keith SVP and Chief Medical Officer Gift −7,333 101,917
2019-03-15 Burke Steven Keith SVP and Chief Medical Officer Gift +7,333 18,999
2019-03-15 Burke Steven Keith SVP and Chief Medical Officer Gift +7,333 26,332
2019-01-31 NOYES TIMOTHY P President and CEO Grant or award · Stock Option (Right to Buy) +350,000 350,000
2019-01-18 Gottlieb Daniel Philip VP Corporate Development Grant or award · Stock Option (Right to Buy) +60,000 60,000
2019-01-18 Toner E. Scott Senior VP of Commercial Grant or award · Stock Option (Right to Buy) +60,000 60,000
2019-01-18 Kowalsky Matthew Paul VP, Legal and Secretary Grant or award · Stock Option (Right to Buy) +60,000 60,000
2019-01-18 Hartman Bradley J VP, People Grant or award · Stock Option (Right to Buy) +70,000 70,000
2019-01-18 Eldridge, George Arthur Sr VP, CFO, Treasr, Asst Secy Grant or award · Stock Option (Right to Buy) +145,000 145,000
2019-01-18 Burke Steven Keith SVP and Chief Medical Officer Grant or award · Stock Option (Right to Buy) +145,000 145,000
2018-12-31 Toner E. Scott Senior VP of Commercial Grant or award +4,117 $1.93 $8K 23,357

Page 18 of 24 · 473 trades